News - Gemifloxacin
2008-07-08 15:00:56
The U.S. Food and Drug Administration says it's notified makers of fluoroquinolone antimicrobial drugs that a boxed warning is necessary for those products.
2008-05-07 09:00:10
Oscient Pharmaceuticals Corporation's (Nasdaq: OSCI) commercialization partner for FACTIVE® (gemifloxacin mesylate) tablets, Menarini Group, a leading European pharmaceutical company based in Italy, has submitted a regulatory filing seeking approval of FACTIVE in Europe.
2007-09-20 15:00:09
CHICAGO, Sept. 20 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , presented further data in support of cethromycin, the Company's lead compound, at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, September 17 - 20.